Therapeutic Potential of Peroxisome Proliferator-Activated Receptors in Chronic Inflammation and Colorectal Cancer
- 30 September 2010
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 39 (3) , 697-707
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory responseJournal of Clinical Investigation, 1999
- Dietary fat and carcinogenesisMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1999
- CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEGastroenterology Clinics of North America, 1999
- Loss-of-Function Mutations in PPARγ Associated with Human Colon CancerMolecular Cell, 1999
- Activators of the nuclear receptor PPARγ enhance colon polyp formationNature Medicine, 1998
- Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ miceNature Medicine, 1998
- Differentiation and reversal of malignant changes in colon cancer through PPARγNature Medicine, 1998
- The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancersCarcinogenesis, 1998
- Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643Carcinogenesis, 1997
- Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs1997